BioCentury
ARTICLE | Clinical News

Nypta tideglusib: Phase IIa data

July 26, 2010 7:00 AM UTC

Noscira S.A., Madrid, Spain Product: Nypta tideglusib ( NP-12) Business: Neurology Molecular target: Glycogen dependent kinase 3 (GSK3) Description: 1,2,4-thiadiazolidine-3,5-dione derivate and glyc...